UroToday3d
Spatial distribution and subtype-specific expression patterns of Nectin-4 in muscle-invasive bladder cancer.
To investigate the expression patterns of Nectin-4, the target molecule of the antibody-drug conjugate enfortumab vedotin (EV), in relation to histological and molecular subtypes of urothelial bladder ...
UroToday4d
Prospective validation study of a combined urine and plasma test for predicting high-grade prostate cancer in biopsy naïve men.
Early and accurate diagnosis of prostate cancer (PC) is crucial for effective treatment. Diagnosing clinically insignificant cancers can lead to overdiagnosis and overtreatment, highlighting the ...
UroToday14d
Comparing Autologous and Mesh Slings for Stress Incontinence Efficacy and Safety - Ariana Smith
Comparing Autologous and Mesh Slings for Stress Incontinence Efficacy and Safety - Ariana Smith ...
UroToday4d
Current insights on PSMA PET/CT in intermediate-risk prostate cancer: a literature review.
The purpose of this systematic review was to evaluate the role of PSMA PET/CT in intermediate-risk prostate cancer (PCa) patients, to determine whether it could help improve treatment strategy and ...
UroToday4d
Evaluating the feasibility of AI-predicted bpMRI image features for predicting prostate cancer aggressiveness: a multi-center study.
To evaluate the feasibility of utilizing artificial intelligence (AI)-predicted biparametric MRI (bpMRI) image features for predicting the aggressiveness of prostate cancer (PCa). A total of 878 PCa ...
UroToday4d
Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer.
Treatment options for recurrent high-risk non-muscle-invasive bladder cancer (HR NMIBC) and muscle-invasive bladder cancer (MIBC) are limited, highlighting a need for clinically effective, accessible, ...
UroToday4d
Comprehensive Genetic Profile of Chinese Muscle-Invasive Bladder Cancer Cohort.
The aim of our study was to characterize the spectrum of mutations in muscle-invasive bladder cancer (MIBC) in the Chinese population, identifying mutational features and exploring potential ...
UroToday7d
A Novel Machine Learning-Based Predictive Model of Clinically Significant Prostate Cancer and Online Risk Calculator - Beyond the Abstract
This recent publication presents a novel machine learning-based predictive model for clinically significant prostate cancer, along with an online risk calculator. The model was developed using a ...
UroToday7d
Why wasn't mirabegron chosen for the first year of the CMS negotiation program?
Importance: The most used overactive bladder (OAB) medications are anticholinergics, which professional societies recommend avoiding in older patients given dementia risk. Cost prevents patients from ...
UroToday7d
Cardiometabolic Index and Stress Urinary Incontinence in US Women: The Mediating Role of the Triglyceride Glucose Index.
Stress urinary incontinence (SUI) is a prevalent condition among women, significantly impairing their quality of life. Emerging evidence suggests that metabolic dysfunction may play a role in the ...
UroToday11d
Botulinum Toxin vs. Sling Surgery for Mixed Urinary Incontinence in Women - Heidi Harvie
Botulinum Toxin vs. Sling Surgery for Mixed Urinary Incontinence in Women - Heidi Harvie ...
UroToday7d
Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder.
Mirabegron, the first-in-class beta-3 agonist, is the mainstay medication for overactive bladder (OAB). The aim of this study was to investigate the efficacy and safety of generic drugs of mirabegron ...